1-4 of 4
John Chapin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BAX 335 Hemophilia B Gene Therapy Phase 1/2 Clinical Trial: Long-Term Safety and Efficacy Follow-up

Miguel Escobar, Barbara Konkle, Jonathan Ducore, Kavitha Rajavel, Kefeng Sun, Brian Yan, John Chapin
Journal: Blood
Blood (2022) 140 (Supplement 1): 10656–10657.
https://doi.org/10.1182/blood-2022-163297
Published: 2022
Journal Articles

Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency

Brief Report
Beth A. Bouchard, John Chapin, Kathleen E. Brummel-Ziedins, Peter Durda, Nigel S. Key, Paula B. Tracy
Journal: Blood
Blood (2015) 125 (23): 3647–3650.
https://doi.org/10.1182/blood-2014-07-589580
Published: 2015
Includes: Supplemental data
Journal Articles

Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies

John Chapin, Stephen Eyler, Richard Smith, Han-Mou Tsai, Jeffrey Laurence
Journal: Blood
Blood (2013) 121 (19): 4012–4013.
https://doi.org/10.1182/blood-2013-03-487694
Published: 2013
Journal Articles

Administration of FFP Repletes and Sustains the Megakaryocyte/Platelet-Derived Factor V Pool To Confer Hemostatic Competence in a Factor V-Deficient Individual.

Beth A. Bouchard, PhD, John Chapin, Nigel S. Key, MD, Paula B. Tracy, PhD
Journal: Blood
Blood (2005) 106 (11): 1779.
https://doi.org/10.1182/blood.V106.11.1779.1779
Published: 2005